Publikationen

• 16th Annual Global CEO Survey – Pharmaceuticals and life sciences industry insights Dealing with disruption – Adapting to survive and thrive

  (English)

  Pharmaceuticals & life sciences companies need to respond to patients’ needs; but they need to understand and cope with the ...

  ---

• Diagnostics 2011 M&A surges, companion diagnostics accelerate, and early detection offers new prospects

  (English)

  PwC's Diagnostics 2011 provides an overview of M&A deal activity during the past two years and the factors driving it, the development ...

  ---

• Insights for pharmaceutical and life science companies: Staying ahead of IFRS challenges

  (English)

  Financial reporting by US companies will undergo unprecedented change over the next several years. International Financial Reporting ...

  ---

• Pay-For-Performance Arrangements: Guidance for Revenue Recognition under IFRS IFRS Revenue Recognition Guidance

  (English)

  Pay-For-Performance is a pricing concept under which the price paid for a given medicine is intended to reflect the economic benefits ...

  ---

• Personalised Medecine in European Hospitals

  (English)

  Personalised medicine brings not only new advances to the European healthcare system today, but also key challenges to adapt to the ...

  ---

• Pharma 2020: From vision to decision November 2012

  (English)

  We look at how pharma companies can reach 2020 in a position to benefit from more favourable conditions thereafter - and the most ...

  ---

• The changing dynamics of pharma outsourcing in Asia Are you readjusting your sights?

  (English)

  The dynamics of pharma outsourcing and location decisions in Asia are changing. Cost reduction is being augmented and companies need ...

  ---

• US Healthcare Reform: Accounting Issues under IFRS

  (English)

  US Healthcare reform has raised some significant accounting issues for the pharmaceutical and life sciences sector, including the ...

  ---